4.5 Article

Exploring the Point-of-Sale Among Vape Shops Across the United States: Audits Integrating a Mystery Shopper Approach

期刊

NICOTINE & TOBACCO RESEARCH
卷 23, 期 3, 页码 495-504

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ntr/ntaa041

关键词

-

资金

  1. National Cancer Institute (NCI) [R01CA215155-01A1]
  2. NCI [R01 CA179422-01, P30 CA138292]
  3. US Fogarty International Center/NCI [1R01TW010664-01]
  4. NIH [SC3GM122628, R01 CA190347]
  5. USDHHS [3GM1226290FK0105-01-00]
  6. US FDA [R01CA204891, U01DA045537, R21DA046333]
  7. TRDRP [27IP-0041, 28IP-0022S]

向作者/读者索取更多资源

The study found that most vape shops in the United States complied with FDA health warnings, free sampling bans, and minimum-age signage. However, there were concerns related to underage access, health claims, promotional strategies, and cannabidiol product offerings, indicating the need for further FDA and state regulatory efforts.
Introduction: Vape shops represent prominent, unique retailers, subject to Food and Drug Administration (FDA) regulation in the United States. Aims and Methods: This study assessed compliance of US vape shop retail marketing strategies with new regulations (eg, required age verification, prohibited free samples) and pre-implementation conditions for other regulations (eg, health warning labels on all nicotine products, required disclosures of e-liquid contents). Results: 95.0% of shops displayed minimum-age signage; however, mystery shoppers were asked for age verification at 35.6% upon entry and at 23.4% upon purchase. Although 85.5% of shops had some evidence of implementing FDA health warnings, 29.1% had signage indicating prohibited health claims, 16.3% offered free e-liquid samples, 27.4% had signage with cartoon imagery, and 33.3% were within two blocks of schools. All shops sold open-system devices, 64.8% sold closed-system devices, 68.2% sold their own brand of e-liquids, 42.5% sold e-liquids containing cannabidiol, 83.2% offered price promotions of some kind, and 89.9% had signage for product and price promotions. Conclusions: Results indicated that most shops complied with some implementation of FDA health warnings and with free sampling bans and minimum-age signage. Other findings indicatedconcerns related to underage access, health claims, promotional strategies, and cannabidiol product offerings, which call for further FDA and state regulatory/enforcement efforts.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据